LSTA:NASDAQ
Lisata Therapeutics Inc
၃.၄၇ US$
၀.၀၀%
(၀.၀၀) 1D
ဇွန် ၂၂, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LSTA...
Mkt. cap
၃.၁၆ ကုဋေ
Avg. vol.
၁.၅၈ သိန်း
Volume
၀.၀၀
52-wk high
၅.၀၇ US$
52-wk low
၁.၈၁ US$
EPS
-၁.၈၆ US$
Beta
၀.၈၁
Shares outstanding
၉.၁၁ သန်း
No. of employees
၂၁
Mkt. cap
၃.၁၆ ကုဋေ
Avg. vol.
၁.၅၈ သိန်း
Volume
၀.၀၀
52-wk high
၅.၀၇ US$
52-wk low
၁.၈၁ US$
EPS
-၁.၈၆ US$
Beta
၀.၈၁
Shares outstanding
၉.၁၁ သန်း
No. of employees
၂၁
News stories
From sources across the web
Stock Titan
·
ပြီးခဲ့သည့် ၁၉ မိနစ်
Microbot Medical (NASDAQ: MBOT) secures first Pennsylvania LIBERTY user and reaches seven U.S. states
Business Wire
·
ပြီးခဲ့သည့် ၂၈ မိနစ်
NASDAQ: ENSG Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm
GlobeNewswire
·
ပြီးခဲ့သည့် ၂၀ မိနစ်
Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented,
Reuters
·
ပြီးခဲ့သည့် ၂ နာရီ
Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
Profile
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
About Lisata Therapeutics Inc
CEO-
Employees၂၁
Founded၁၉၈၀
HeadquartersBasking Ridge, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitelisata.com
AI content may include mistakes. Learn more